EdgarLookup

ArriVent BioPharma, Inc. — All Filings

136 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-Q 3 4 424B4 424B5 8-A12B 8-K 8-K/A ARS CERT CORRESP D D/A DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT S-1 S-1/A S-1MEF S-3ASR S-8 SC 13D SC 13G SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
8-K 8-K 0001104659-26-029588 Mar 17, 2026
S-8 FORM S-8 0001104659-26-024136 Mar 5, 2026
10-K 10-K 0001104659-26-024127 Mar 5, 2026 Dec 31, 2025
8-K 8-K 0001104659-26-024112 Mar 5, 2026
SCHEDULE 13G/A 0001104659-26-023750 Mar 5, 2026
SCHEDULE 13G/A 0002058093-26-000004 Feb 17, 2026
SCHEDULE 13G/A 0000902664-26-001013 Feb 17, 2026
4 OWNERSHIP DOCUMENT 0001104659-26-010478 Feb 4, 2026 Feb 2, 2026
4 OWNERSHIP DOCUMENT 0001104659-26-010477 Feb 4, 2026 Feb 2, 2026
4 OWNERSHIP DOCUMENT 0001104659-26-010473 Feb 4, 2026 Feb 2, 2026
4 OWNERSHIP DOCUMENT 0001104659-26-010472 Feb 4, 2026 Feb 2, 2026
4 OWNERSHIP DOCUMENT 0001104659-26-010471 Feb 4, 2026 Feb 2, 2026
4 0000902664-26-000675 Feb 3, 2026 Dec 10, 2025
SCHEDULE 13G/A 0000102909-26-000090 Jan 30, 2026
SCHEDULE 13G 0002012383-26-000643 Jan 21, 2026
SCHEDULE 13G/A 0001214659-25-016716 Nov 14, 2025
10-Q 10-Q 0001104659-25-108847 Nov 10, 2025 Sep 30, 2025
8-K 8-K 0001104659-25-108839 Nov 10, 2025
SCHEDULE 13G/A 0000315066-25-002677 Nov 5, 2025
SCHEDULE 13G 0000102909-25-000025 Oct 30, 2025
SCHEDULE 13G/A 0002012383-25-002500 Oct 17, 2025
SCHEDULE 13G 0001104659-25-099728 Oct 15, 2025
8-K 8-K 0001558370-25-011954 Sep 9, 2025
SCHEDULE 13G/A 0001415889-25-021943 Aug 14, 2025
SCHEDULE 13D/A 0000947871-25-000764 Aug 13, 2025
SCHEDULE 13G/A 0000919574-25-004712 Aug 13, 2025
SCHEDULE 13G 0002058093-25-000008 Aug 13, 2025
10-Q 10-Q 0001558370-25-010975 Aug 11, 2025 Jun 30, 2025
8-K 8-K 0001558370-25-010974 Aug 11, 2025
8-K FORM 8-K 0001104659-25-069169 Jul 21, 2025
4 OWNERSHIP DOCUMENT 0001104659-25-067928 Jul 15, 2025 Jul 11, 2025
424B5 424B5 0001104659-25-065391 Jul 2, 2025
8-K FORM 8-K 0001104659-25-065386 Jul 2, 2025 Jul 1, 2025
424B5 424B5 0001104659-25-064736 Jul 1, 2025
8-K FORM 8-K 0001104659-25-061375 Jun 23, 2025
4 OWNERSHIP DOCUMENT 0001104659-25-061270 Jun 20, 2025 Jun 18, 2025
4 OWNERSHIP DOCUMENT 0001104659-25-061269 Jun 20, 2025 Jun 18, 2025
4 OWNERSHIP DOCUMENT 0001104659-25-061268 Jun 20, 2025 Jun 18, 2025
4 OWNERSHIP DOCUMENT 0001104659-25-061267 Jun 20, 2025 Jun 18, 2025
8-K FORM 8-K 0001104659-25-061165 Jun 20, 2025 Jun 18, 2025
SCHEDULE 13G 0002058093-25-000002 May 15, 2025
10-Q 10-Q 0001558370-25-007276 May 12, 2025 Mar 31, 2025
8-K 8-K 0001558370-25-007259 May 12, 2025
4 OWNERSHIP DOCUMENT 0001104659-25-041344 Apr 29, 2025 Apr 28, 2025
3 OWNERSHIP DOCUMENT 0001104659-25-041340 Apr 29, 2025 Apr 28, 2025
ARS ARS 0001104659-25-040239 Apr 28, 2025 Dec 31, 2024
DEFA14A DEFA14A 0001104659-25-040227 Apr 28, 2025
DEF 14A DEF 14A 0001104659-25-040214 Apr 28, 2025 Jun 18, 2025
8-K FORM 8-K 0001104659-25-039799 Apr 28, 2025 Apr 23, 2025
8-K 8-K 0001558370-25-002912 Mar 13, 2025 Mar 11, 2025